Journal
ONCOLOGIST
Volume 26, Issue 5, Pages E902-E902Publisher
WILEY
DOI: 10.1002/onco.13703
Keywords
-
Categories
Ask authors/readers for more resources
This letter to the editor discusses a recent article on the use of NUC-1031 and cisplatin in patients with biliary tract cancer, comparing the results to the landmark ABC-02 trial.
This letter to the editor remarks on a recently published article on the use of NUC-1031 and cisplatin for patients with biliary tract cancer and compares results of the landmark ABC-02 trial.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available